Time-Resolved Fluorescence Immunoassay Analyzer

What is the Time-Resolved Fluorescence Immunoassay Analyzer?

A time-resolved fluorescence analyzer uses lanthanide chelate labels with long emission lifetimes and starts measuring after short-lived background fluorescence has decayed. It delivers very low detection limits and suits laboratories measuring hormones, tumour markers and other low-concentration analytes.

Overview

The sample is reacted with a lanthanide-labelled antibody, most often europium or samarium, and the label is either measured directly or released into solution by an enhancement step that forms a highly fluorescent chelate. The instrument excites with a pulsed light source, waits for a delay of a few hundred microseconds and then counts emission over a defined window. During the delay, background fluorescence from serum proteins and plastic decays, while the lanthanide signal persists because its lifetime is measured in hundreds of microseconds to milliseconds. This gives a very high signal-to-background ratio, so assays for markers such as thyroid stimulating hormone, ferritin and hepatitis antigens reach low detection limits. The technology is commonly used in plate or microsphere formats, and in multiplex systems where several lanthanides with different lifetimes and wavelengths encode different analytes.

How does it work?

Fluorescence immunoassay uses an antibody labelled with a fluorophore such as fluorescein, a europium chelate or a quantum dot. After the immune complex forms, the label is excited by light of one wavelength and emits light at a longer wavelength, and a photodetector measures the emission after optical filtering. The difference between excitation and emission wavelengths allows the instrument to separate the signal from the excitation light, and background fluorescence from sample components is reduced by careful filter selection, by washing away unbound label and, in time-resolved systems, by delaying the measurement until short-lived background fluorescence has decayed. Since the fluorescent signal is measured against a low background, sensitivity is generally better than absorbance-based enzyme immunoassay. Quantification relies on a calibration curve stored in the analyzer, and strip-based tests use a reader that scans the test and control lines.

What are the key features?

• Pulsed excitation with delayed emission counting
• Lanthanide chelate labels with long fluorescence lifetime
• Measurement window set to exclude short-lived background
• Very high signal-to-background ratio for low detection limits
• Plate or microsphere formats with batch processing
• Multiplex option using different lanthanide labels

What are the technical specifications?

A typical time-resolved fluorescence immunoassay analyzer configuration offers labels of Eu3+, Sm3+, Tb3+ chelates, fluorescence lifetime of Hundreds of microseconds to milliseconds, delay time of 200–600 µs programmable, counting window of 400–1000 µs, detection limit of Assay specific, down to picomolar levels and plate formats of 96-well and 384-well plates or microsphere carriers. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.

Which applications is it used for?

The Time-Resolved Fluorescence Immunoassay Analyzer is used in neonatal and thyroid hormone testing, tumour marker and ferritin measurement, infectious disease antigen screening and multiplex research immunoassays. Across the wider Fluorescence Immunoassay class, laboratories also deploy it for point-of-care cardiac and inflammation testing, hormone and fertility testing in clinics and infectious disease antigen detection.

Which standards and certifications apply?

Relevant standards and methods include ISO 15189, CLSI EP05, CLSI EP15, CLSI EP17, CLSI POCT04, IEC 61010-1 and IEC 61010-2-101. Certification candidates for this model are CE, ISO 13485 manufacturing and NMPA class II registration; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.

Keep the instrument away from strong ambient light and place it on a stable bench, because stray light and vibration reduce fluorescence measurement precision. Verify performance at installation with the manufacturer's calibration material and with controls at two or three levels, and check the optical path and detector gain as specified. Daily tasks include control measurement and checking that the correct assay lot and curve are selected. Lateral flow readers require consistent sample application volume, controlled reading time after the reaction and careful handling of cartridges, since a delay of a few minutes can change the result near a cut-off. Store cartridges and reagents within their temperature range, use them before expiry, and treat all used devices as infectious waste.

How do I select the right Time-Resolved Fluorescence Immunoassay Analyzer?

Choose time-resolved fluorescence when the clinical decision point for your analytes lies near the detection limit of conventional methods, or when batch processing of hormone and tumour marker panels is routine. In the RFQ confirm the detection limit and functional sensitivity for each key analyte, the enhancement reagent requirements, and whether the software supports the curve models your kits specify.

How does it compare with other Fluorescence Immunoassay variants?

Choose the format from the clinical setting: a strip or cartridge reader suits single tests at the point of care, while a plate or automated platform suits batch testing in a laboratory. Then check the assay menu and its regulatory status, because fluorescence platforms are kit specific and an instrument without the tests you need has no value. Compare sensitivity at the clinical decision point, measuring range, sample volume and time to result, which ranges from ten minutes for lateral flow to several hours for batch formats. For quantitative work, confirm that the analyzer stores calibration curves per lot and applies them automatically by reading a cartridge barcode. Consider whether fluorescence interference from bilirubin, haemoglobin or medication is documented for each assay, and whether controls and calibration material are available locally.